Diagnosis of GM-1 gangliodosis in Cuba

Diagnosis of GM-1 gangliodosis in Cuba

Show other versions (1)

<strong>Background:</strong> GM-1 gangliosidosis is included in the group of lysosomal diseases and is characterized by a deficiency of the enzyme b-galactosidase, which as a consequence produces accumulation of GM1 ganglioside in nervous cells and galactosil oligosaccharides and product...

Full description

Bibliographic Details
Main Authors:	Caridad Menéndez Saínz, Sergio González García, Claudina Zaldívar Muñoz, Alina González-Quevedo Monteagudo
Format:	Article
Language:	Spanish
Published:	Centro Provincial de Información de Ciencias Médicas. Cienfuegos 2007-05-01
Series:	Medisur
Subjects:	enfermedades lisosomales gangliosidosis gm-1 b-galactosidasa
Online Access:	http://www.medisur.sld.cu/index.php/medisur/article/view/257

Similar Items

Diagnosis of GM-1 gangliodosis in Cuba
by: Caridad Menéndez Saínz, et al.
Published: (2007-05-01)

Enfermedades por depósito Lisosomal en Reumatología. Cuando pensar en ellas?
by: María Silvia Larroudé
Published: (2015-07-01)

Anàlisi genètica i molecular de les malalties Gangliosidosi GM1 i Morquio B
by: Santamaría Merino, Raúl
Published: (2007)

Aspectos clínicos, radiológicos e neuroimagem em 12 pacientes com Gangliosidose GM1, formas juvenil e crônica
by: Kannebley, João Stein, 1971-
Published: (2015)

Brain ceramide hexosides in Tay-Sachs disease and generalized gangliosidosis (GM1-gangliosidosis)
by: Kunihiko Suzuki, et al.
Published: (1967-03-01)

Progressive dystonia as a presenting manifestation of GM1 gangliosidosis
by: Sahil Mehta, et al.
Published: (2019-01-01)

Juvenile GM2 Gangliosidoses
by: J Gordon Millichap
Published: (2006-11-01)

Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience
by: Rita Fischetto, et al.
Published: (2020-10-01)

GM1 gangliosidosis associated with neonatal-onset of diffuse ecchymoses and mongolian spots
by: Imad Dweikat, et al.
Published: (2011-01-01)

Feasibility study of cyclodextrins as active pharmaceutical ingredients for the treatment of GM1-gangliosidosis
by: Yuki Maeda, et al.
Published: (2016-02-01)

Wishbone pattern of iron accumulation: A pathognomonic sign of type III GM1 gangliosidosis
by: Shweta Prasad, et al.
Published: (2019-01-01)

Gangliosidosis generalizada tipo 1
by: Iván Hernández García, et al.

The effect of Mycoplasma and mycoplasma removal agent on the hydrolase activity in fibroblasts of patients with lysosomal diseases Efecto de Mycoplasma y del agente de eliminación de micoplasmas en la actividad de las hidrolasas en fibroblastos de pacientes con enfermedades lisosomales
by: F. T. S. Souza, et al.
Published: (2010-02-01)

GM1 Gangliosidosis Type 1 and Mongolian Spots
by: J Gordon Millichap
Published: (2013-06-01)

Case reports of juvenile GM1 gangliosidosisis type II caused by mutation in GLB1 gene
by: Parvaneh Karimzadeh, et al.
Published: (2017-07-01)

Myelin abnormalities in the optic and sciatic nerves of mice with GM1-gangliosidosis
by: Heinecke, Karie A.
Published: (2014)

Chitotriosidase as a biomarker for gangliosidoses
by: Sarah Kim, et al.
Published: (2021-12-01)

Atypical juvenile presentation of GM2 gangliosidosis AB in a patient compound-heterozygote for c.259G>T and c.164C>T mutations in the GM2A gene
by: Carla Martins, et al.
Published: (2017-06-01)

An Evalution of the Demographic and Clinical Characterictics of Patients with GM2 Gangliosidosis
by: Esra Er, et al.
Published: (2018-03-01)

GM1 Gangliosidosis: Mechanisms and Management
by: Rha AK, et al.
Published: (2021-04-01)

Análise de mutações no gene GLB1 em pacientes com gangliosidose GM1 formas juvenil e crônica
by: Baptista, Marcella Bergamini de, 1988-
Published: (2013)

Examination of a blood-brain barrier targeting β-galactosidase-monoclonal antibody fusion protein in a murine model of GM1-gangliosidosis
by: Michael J. Przybilla, et al.
Published: (2021-06-01)

GM1 Gangliosidosis—A Mini-Review
by: Elena-Raluca Nicoli, et al.
Published: (2021-09-01)

Clinical findings in Brazilian patients with adult GM1 gangliosidosis
by: Luciana Giugliani, et al.
Published: (2019-09-01)

Enfermedad de fabry
by: Martín Gómez Luján
Published: (2018-08-01)

White Matter Pathology as a Barrier to Gangliosidosis Gene Therapy
by: Anne S. Maguire, et al.
Published: (2021-08-01)

Animal models of GM2 gangliosidosis: utility and limitations
by: Lawson CA, et al.
Published: (2016-07-01)

Biochemical characterization of the GM2 gangliosidosis B1 variant
by: J.C. Tutor
Published: (2004-06-01)

A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease)
by: Elin Haf Davies, et al.
Published: (2020-08-01)

Transient high-level expression of ß-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA
by: R.C. Balestrin, et al.
Published: (2008-04-01)

Two‐Year Follow‐Up Magnetic Resonance Imaging and Spectroscopy Findings and Cerebrospinal Fluid Analysis of a Dog with Sandhoff's Disease
by: D. Ito, et al.
Published: (2018-03-01)

Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis
by: Francesca Ornaghi, et al.
Published: (2020-02-01)

Genetics of Juvenile Spinal Muscular Atrophy
by: J Gordon Millichap
Published: (1997-06-01)

An Inducible Mouse Model of Late Onset Tay–Sachs Disease
by: Mylvaganam Jeyakumar, et al.
Published: (2002-08-01)

Evaluación de la actividad de la enzima lisosomal beta-galactosidasa en muestras de fibroblastos lisados dispuestos sobre papel filtro
by: Betta Morales, Katerina Angélica
Published: (2018)

Enfermedad de Tay-Sachs
by: Albia Josefina Pozo Alonso, et al.

Errores innatos del metabolismo: Enfermedades lisosomales
by: Caridad Menéndez Saínz, et al.
Published: (2002-03-01)

Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased <sup>1</sup>H NMR-Linked Metabolomics Strategy
by: Benita C. Percival, et al.
Published: (2021-03-01)

Enfermedad de Fabry. Discapacitante y subdiagnosticada
by: Carmen Velázquez Arce
Published: (2016-03-01)

Real-time MR tracking of AAV gene therapy with βgal-responsive MR probe in a murine model of GM1-gangliosidosis
by: Toloo Taghian, et al.
Published: (2021-12-01)